Fishy ITA STOCK NOTEBOOK

Medical-Biomed/Biotech Group

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders.

EPS % Chg (Last Qtr): 158%

3 Year EPS Growth Rate: 147%

EPS Est % Chg (Current Year): 50%

ROE: 29.2%

Sales % Chg (Last Qtr): 57%

3 Year Sales Growth Rate: 36%

Debt/equity : 0.9

Profit Margin: 33.0%

PE: 36

Dividend Yield: 0

Buyback Yield %: 0